Literature DB >> 20546883

Passive diffusion of acetylcholinesterase oxime reactivators through the blood-brain barrier: influence of molecular structure.

Jana Zdarova Karasova1, Miroslav Pohanka, Kamil Musilek, Filip Zemek, Kamil Kuca.   

Abstract

In this in vitro study, high-performance liquid chromatography (HPLC) was used to determinate the penetration of 30 acetylcholinesterase (AChE) reactivators through the blood-brain barrier (BBB). According to our method, monoquaternary AChE reactivators were found to be able to penetrate the BBB. In addition to molecular structure, molecular weight appears to be an important factor for passive transport of oximes through the BBB. For bisquaternary reactivators, the connecting linker plays a key role in the ability to penetrate into the central nervous system (CNS): simple, short linkers tend to facilitate permeation. The location of groups on the pyridine ring also influences passive transport into the brain; the optimum position of the oxime group was found to be position four (para) and substitution of the oxime group on the pyridine ring by carbamoyl or amidoxime group markedly decreased penetration of AChE reactivators into the CNS. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546883     DOI: 10.1016/j.tiv.2010.05.009

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

Review 1.  Recent developments on oximes to improve the blood brain barrier penetration for the treatment of organophosphorus poisoning: a review.

Authors:  Mohd Nor Faiz Norrrahim; Mas Amira Idayu Abdul Razak; Noor Aisyah Ahmad Shah; Herdawati Kasim; Wan Yusmawati Wan Yusoff; Norhana Abdul Halim; Siti Aminah Mohd Nor; Siti Hasnawati Jamal; Keat Khim Ong; Wan Md Zin Wan Yunus; Victor Feizal Knight; Noor Azilah Mohd Kasim
Journal:  RSC Adv       Date:  2020-01-27       Impact factor: 4.036

2.  Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.

Authors:  Li-Li Zou; Jie-Lan Ma; Tao Wang; Tang-Bin Yang; Chang-Bai Liu
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

3.  Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study.

Authors:  Vendula Sepsova; Jana Zdarova Karasova; Jan Korabecny; Rafael Dolezal; Filip Zemek; Brian J Bennion; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2013-08-16       Impact factor: 5.923

4.  The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats.

Authors:  Filip Caisberger; Jaroslav Pejchal; Jan Misik; Jiri Kassa; Martin Valis; Kamil Kuca
Journal:  BMC Pharmacol Toxicol       Date:  2018-06-28       Impact factor: 2.483

5.  The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.

Authors:  Jiri Kassa; Jan Misik; Jana Hatlapatkova; Jana Zdarova Karasova; Vendula Sepsova; Filip Caisberger; Jaroslav Pejchal
Journal:  Molecules       Date:  2017-07-11       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.